Searched for
SYNGENE STOCK UPDATE
Syngene International shares in focus after positive USFDA updates for 2 Bengaluru facilitiesSyngene International shares:The initial update concerns a Good Clinical Practices (GCP) compliance inspection carried out at Syngene’s Sem...- Macquarie initiates coverage on Divi’s Labs, 3 CRDMO firms with up to 40% upside potentialThe global brokerage firm highlights that Indian CDMO companies trade at a 2-year forward EV/EBITDA of 20x, compared to 16x for regional an...
- Bharat Forge among 9 mid cap stocks which hit all-time high on WednesdayThese MidCap Index stocks have defied market dynamics, reaching new all-time highs on September 6, 2023.
- Asian Paints, Ashok Leyland among 10 stocks in overbought zoneThe RSI is a valuable technical indicator that measures the strength and momentum of a stock's price movement. Ranging from 0 to 100, an RS...
- Stock Radar: Breakout from Descending Channel could take this healthcare stock to fresh record highsWhile the stock has failed to hold its record high and is considered to be overbought, it's still viewed as a profitable investment as it h...
- Bank Nifty poised to move towards 41,500; gold can reach $2100 and crude may inch up to $6,700: Rajesh Palviya“The Pharma Index is now trading above its 50-day moving average, indicating that buying interest is likely to continue in the short term.”
- Market trading guide: Zydus Lifesciences among 4 stock recommendations for Monday
- Stocks in the news: RIL, Ultratech, NTPC, IndiGo, Cipla, NDTV and fertilizers stocksReliance Industries wil host its 45th post IPO annual general meeting on Monday. The traders be keenly looking an update from its chairman ...
- Global brokerages see up to 115% upside in Tata Steel, Vedanta, Gland PharmaThe brokerage believes that weakness in China's export prices will dent the company, leading to an EBITDA cut by 32-34 per cent on the back...
- Syngene International skids 4% as Q4 PAT declines 8% YoYOn a standalone basis, the company’s quarterly net profit stood at Rs 147 crore in March 2022, down 8.41 per cent from Rs 160.50 crore in M...
- 4 largecaps with consistent score improvement and upside potential of up to 29%The four shortlisted stocks have a minimum upside potential of 10%.
- Inflation, Omicron spook D-Street bulls; investors lose Rs 1 lakh crEquity investors were left poorer by Rs 1.06 lakh crore by the end of the day. Stocks from sectors, barring some IT names, saw selling. Ban...
- Ahead of Market: 12 things that will decide stock action on WednesdayMazhar Mohammad of Chartviewindia.in said Nifty breaking out of the consolidation phase suggests the index is now eyeing the 16,300 level.
- Mid and smallcap stocks to lead next leg of rallyBanking and NBFCs, cement or even auto ancillary stocks from broader market to take the market higher, says Hemang Jani
- The week that was in 10 stocks: ITC, Cipla, M&M & stocks that gained up to 25%Here are top stocks and sectors that created all the buzz during the week gone by.
- Mapping the market: Fed relief lifts BSE M-cap by Rs 1L cr; Aurobindo, Sadbhav rallyThe BSE Sensex surged 266 points, or 0.93 per cent, to settle at 28,773. The Nifty50 could not kiss the 8,900 mark, but managed to climb 1....
- Newly-listed IPOs bleed most in January market meltdownInterGlobe last week lost 19% of its market value in a single day on concerns over increased competition, rising input cost and delay in ai...
- Retail investors return to IPO mart; Pathlabs, Alkem issues lapped upThe silver lining has really been retail investors, who showed huge interest on the PathLabs issue by oversubscribing the quota.
- IPO mart looks to end eventful year with a bangThe domestic equity market has had a rather lacklustre year, but the IPO market seems ready to sign off an eventful year with a bang.
- Is it time to book profits on Biocon counter post Syngene listing?Biocon has gained nearly 9 per cent in the past six months, compared to a 2 per cent fall in the BSE benchmark Sensex.
Load More
